Kathrine E. Attfield

2.7k total citations · 1 hit paper
16 papers, 979 citations indexed

About

Kathrine E. Attfield is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Kathrine E. Attfield has authored 16 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Kathrine E. Attfield's work include T-cell and B-cell Immunology (7 papers), Multiple Sclerosis Research Studies (3 papers) and Immune Cell Function and Interaction (3 papers). Kathrine E. Attfield is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Multiple Sclerosis Research Studies (3 papers) and Immune Cell Function and Interaction (3 papers). Kathrine E. Attfield collaborates with scholars based in United Kingdom, Denmark and Germany. Kathrine E. Attfield's co-authors include Lars Fugger, Manuel A. Friese, Lise Torp Jensen, Max Kaufmann, Anne Willing, Nina Kursawe, Martin J. Glennie, Margaret M. Esiri, Ruth Etzensperger and Sandra Vergo and has published in prestigious journals such as Nature Communications, Blood and Nature Neuroscience.

In The Last Decade

Kathrine E. Attfield

15 papers receiving 972 citations

Hit Papers

The immunology of multiple sclerosis 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathrine E. Attfield United Kingdom 13 469 317 271 151 145 16 979
Marvin M. van Luijn Netherlands 18 571 1.2× 223 0.7× 434 1.6× 190 1.3× 202 1.4× 43 1.1k
Jennifer L. Berard Canada 9 321 0.7× 238 0.8× 220 0.8× 321 2.1× 134 0.9× 9 929
Michael Friese Germany 6 435 0.9× 105 0.3× 437 1.6× 186 1.2× 127 0.9× 10 925
Ryan C. Winger United States 12 450 1.0× 279 0.9× 254 0.9× 147 1.0× 145 1.0× 25 946
Mark Marriott Australia 13 207 0.4× 130 0.4× 296 1.1× 102 0.7× 127 0.9× 28 758
Ingrid Teige Sweden 14 556 1.2× 229 0.7× 102 0.4× 175 1.2× 274 1.9× 40 939
Katarzyna Biernacki Canada 15 399 0.9× 182 0.6× 255 0.9× 481 3.2× 155 1.1× 19 1.1k
Andreas Schulte‐Mecklenbeck Germany 19 630 1.3× 270 0.9× 435 1.6× 282 1.9× 177 1.2× 53 1.3k
Annet F. Wierenga‐Wolf Netherlands 21 750 1.6× 287 0.9× 475 1.8× 367 2.4× 181 1.2× 39 1.5k
Cheng‐Chih Hsiao Netherlands 19 459 1.0× 491 1.5× 186 0.7× 345 2.3× 134 0.9× 37 1.2k

Countries citing papers authored by Kathrine E. Attfield

Since Specialization
Citations

This map shows the geographic impact of Kathrine E. Attfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrine E. Attfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrine E. Attfield more than expected).

Fields of papers citing papers by Kathrine E. Attfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrine E. Attfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrine E. Attfield. The network helps show where Kathrine E. Attfield may publish in the future.

Co-authorship network of co-authors of Kathrine E. Attfield

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrine E. Attfield. A scholar is included among the top collaborators of Kathrine E. Attfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrine E. Attfield. Kathrine E. Attfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Attfield, Kathrine E., Kristian Steen Frederiksen, Giovanni B. Frisoni, et al.. (2025). Investigating the Effects of Semaglutide in Early Alzheimer’s Disease Using Single-cell Transcriptomics and Proteomics – Rationale and Design (P12-3.017). Neurology. 104(7_Supplement_1).
2.
Jensen, Lise Torp, Kathrine E. Attfield, & Lars Fugger. (2024). A repair pathway lost in multiple sclerosis provides a new drug opportunity. Nature Immunology. 25(3). 385–386. 1 indexed citations
3.
Jensen, Lise Torp, Kathrine E. Attfield, Marc Feldmann, & Lars Fugger. (2023). Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors. EBioMedicine. 97. 104840–104840. 32 indexed citations
4.
Kaufmann, Max, Fabian Coscia, Calliope A. Dendrou, et al.. (2022). Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nature Neuroscience. 25(7). 944–955. 81 indexed citations
5.
Attfield, Kathrine E., Lise Torp Jensen, Max Kaufmann, Manuel A. Friese, & Lars Fugger. (2022). The immunology of multiple sclerosis. Nature reviews. Immunology. 22(12). 734–750. 196 indexed citations breakdown →
6.
Kaufmann, Max, Hayley G. Evans, Jan Broder Engler, et al.. (2021). Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. Med. 2(3). 296–312.e8. 57 indexed citations
7.
Evans, Hayley G., Kathrine E. Attfield, Christiane Desel, et al.. (2020). A novel neurodegenerative spectrum disorder in patients with MLKL deficiency. Cell Death and Disease. 11(5). 303–303. 19 indexed citations
8.
Attfield, Kathrine E., et al.. (2020). Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient. Multiple Sclerosis Journal. 26(10). 1261–1264. 24 indexed citations
9.
Kaur, Gurman, Stéphanie Gras, Jesse I. Mobbs, et al.. (2017). Structural and regulatory diversity shape HLA-C protein expression levels. Nature Communications. 8(1). 15924–15924. 77 indexed citations
10.
Rühl, Geraldine, Atanas Patronov, Katherina Siewert, et al.. (2016). Multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 3(4). e241–e241. 7 indexed citations
11.
Willing, Anne, Oliver Leach, Friederike Ufer, et al.. (2014). CD8+MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL‐18 serum levels in multiple sclerosis. European Journal of Immunology. 44(10). 3119–3128. 125 indexed citations
13.
Attfield, Kathrine E., Calliope A. Dendrou, & Lars Fugger. (2012). Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis. Immunological Reviews. 248(1). 10–22. 12 indexed citations
14.
Vergo, Sandra, Matthew Craner, Ruth Etzensperger, et al.. (2011). Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain. 134(2). 571–584. 135 indexed citations
15.
Beers, Stephen A., H.T. Claude Chan, Sonya James, et al.. (2008). Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood. 112(10). 4170–4177. 125 indexed citations
16.
Taraban, Vadim Y., Sonya Martin, Kathrine E. Attfield, et al.. (2008). Invariant NKT Cells Promote CD8+ Cytotoxic T Cell Responses by Inducing CD70 Expression on Dendritic Cells. The Journal of Immunology. 180(7). 4615–4620. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026